Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

SMITHKLINE BEECHAM'S CITRUCEL "RELIEF WITHOUT GAS" IV AD

This article was originally published in The Tan Sheet

Executive Summary

SMITHKLINE BEECHAM'S CITRUCEL "RELIEF WITHOUT GAS" IV AD will continue to air but may include an additional superimposed message emphasizing that the claim is based on laboratory, not clinical, testing, according to the company. SmithKline Beecham is considering whether to modify an ongoing TV ad campaign for the bulk laxative, which began Nov. 1, 1993, in response to recommendations by the National Advertising Division of the Council of Better Business Bureaus.

You may also be interested in...



Citrucel Claim That Metamucil Causes Excess Gas Expelled After 20 Years

GlaxoSmithKline will discontinue claim P&G's Metamucil product causes excess gas and it Citrucel doesn't after P&G presented evidence that met NAD's standard for reopening a review. The industry self-regulation organization found GSK could no longer support its claim.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

Topics

UsernamePublicRestriction

Register

PS083102

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel